Exane Derivatives Becton Dickinson & CO Transaction History

Exane Derivatives

$157 Million
Q2 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$234.74 - $275.42 $16,901 - $19,830	-72 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$243.64 - $270.48 $355,227 - $394,359	-1,458 Reduced 95.29%	72 $18,000
Q4 2021 Jan 28, 2022	SELL	$230.08 - $250.94 $187,055 - $204,014	-813 Reduced 34.7%	1,530 $375,000
Q3 2021 Oct 26, 2021	BUY	$232.72 - $256.47 $404,932 - $446,257	1,740 Added 288.56%	2,343 $561,000
Q2 2021 Jul 28, 2021	BUY	$232.65 - $254.58 $140,287 - $153,511	603 New	603 $143,000
Q1 2021 Apr 30, 2021	SELL	$232.09 - $256.88 $336,530 - $372,476	-1,450 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$221.92 - $245.94 $33,509 - $37,136	151 Added 11.62%	1,450 $353,000
Q3 2020 Oct 06, 2020	SELL	$215.77 - $276.76 $93,859 - $120,390	-435 Reduced 25.09%	1,299 $294,000
Q2 2020 Jul 10, 2020	BUY	$219.9 - $263.41 $312,697 - $374,569	1,422 Added 455.77%	1,734 $404,000
Q4 2019 Jan 22, 2020	BUY	$236.45 - $266.82 $15,369 - $17,343	65 Added 26.32%	312 $82,000
Q2 2019 Jul 12, 2019	BUY	$217.4 - $246.08 $53,697 - $60,781	247 New	247 $0
Q1 2019 Apr 24, 2019	SELL	$206.05 - $248.17 $457,637 - $551,185	-2,221 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$204.73 - $257.93 $300,953 - $379,157	1,470 Added 195.74%	2,221 $488,000
Q3 2018 Oct 24, 2018	BUY	$233.07 - $256.0 $4,661 - $5,120	20 Added 2.74%	751 $0
Q2 2018 Oct 24, 2018	BUY	$208.1 - $233.85 $152,121 - $170,944	731 New	731 $0
Q2 2018 Jul 19, 2018	SELL	$208.1 - $233.85 $149,832 - $168,372	-720 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$205.46 - $240.27 $3,698 - $4,324	18 Added 2.56%	720 $0
Q4 2017 Jan 29, 2018	BUY	$189.0 - $222.64 $118,692 - $139,817	628 Added 848.65%	702 $0
Q3 2017 Oct 18, 2017	BUY	$186.89 - $198.9 $13,829 - $14,718	74	74 $0

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account